Breast Biopsy Market

The report "Breast Biopsy Devices Market by Product (Needle: Core, FNAB, VAB; Equipment, Wire, Guidance system, Table, Assay kit), Procedure (Needle, Liquid: CTC, CTDNA; Open), Application (Screening, Monitoring), End User (Hospital, Clinic) - Global Forecasts to 2030", is expected to reach USD 3,261.7 million by 2030 from USD 2,384.1 million in 2025, at a CAGR of 6.5% during the forecast period.

Browse 230 market data Tables and 45 Figures spread through 320 Pages and in-depth TOC on "Breast Biopsy Devices Market by Product (Needle: Core, FNAB, VAB; Equipment, Wire, Guidance system, Table, Assay kit), Procedure (Needle, Liquid: CTC, CTDNA; Open), Application (Screening, Monitoring), End User (Hospital, Clinic) - Global Forecasts to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market-189011805.html

The growth of the breast biopsy market is primarily driven by the rising global incidence of breast cancer, increasing population awareness, the adoption of early diagnostic screening programs, and advancements in minimally invasive biopsy technologies. Techniques such as image-guided and vacuum-assisted biopsy systems improve accuracy and reduce patient discomfort, leading to greater clinical adoption. Furthermore, the expansion of healthcare infrastructure in emerging markets, increased investment in women's health, and favorable reimbursement policies in developed countries further stimulate demand in the market. The shift towards outpatient and ambulatory care settings also encourages the use of cost-effective and rapid biopsy procedures.

“The biopsy needles segment is expected to register the highest CAGR during the forecast period.”

Based on products, the global breast biopsy devices market is categorized into several segments: biopsy needles, biopsy equipment, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products. Among these, the biopsy needles segment is expected to experience the highest growth rate during the forecast period. This growth can be attributed to the rising incidence of cancer worldwide and the increased demand for accurate diagnostics and testing.

Biopsy needles are utilized in minimally invasive procedures, such as core needle biopsy (CNB) and fine needle aspiration biopsy (FNAB), providing a pain-free method for tissue sampling with shorter recovery times compared to traditional surgical methods. Technological advancements supporting the biopsy needles market include vacuum-assisted and ultrasound-assisted biopsy needle systems and the development of needle systems that incorporate diagnostic imaging techniques, such as ultrasound, CT, and MRI.

“The liquid breast biopsy segment is expected to register a significant growth rate over the forecast period.”

Based on procedure, the breast biopsy devices market is divided into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. The liquid breast biopsy segment is expected to experience the highest growth rate during the forecast period. This growth can be attributed to the increasing use of liquid mammary biopsies, which are non-invasive, provide quick results, and allow for real-time analysis of tumor dynamics. Unlike traditional tissue biopsies, liquid biopsies analyze circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) collected from a blood sample. This approach enables early detection, monitoring of treatment responses, and identification of mutations related to drug resistance.

“The early cancer screening segment accounted for the largest share of the breast biopsy devices market, by application, in 2024.”

Based on applications, the global breast biopsy devices market is segmented into four main categories: early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. In 2024, early cancer screening represented the largest share of the market. The rise in various available screening technologies that enhance detection rates, such as digital mammography, artificial intelligence-assisted imaging, and genetic risk assessments, has contributed to advancements in this area. These innovations lead to higher sensitivity and improved specimen availability. Additionally, strong government initiatives, including public health campaigns and increased awareness among individuals, have resulted in greater accessibility to and participation in routine screenings by patients and wider populations.

“The hospital & surgical centers segment accounted for the largest share of the breast biopsy devices market, by end user, in 2024.”

Based on end users, the breast biopsy devices market is divided into hospitals & surgical centers, breast care centers, and imaging clinics & diagnostic centers. In 2024, hospitals & surgical centers were the largest segment in the breast biopsy devices market. This growth is primarily due to their advanced infrastructure, streamlined diagnostic processes, and high patient volumes. Most hospitals and surgical centers are equipped with cutting-edge imaging technologies, such as MRI, ultrasound, and digital mammography, allowing them to conduct biopsy procedures in a more accurate and less invasive manner.

“North America accounted for the largest share of the breast biopsy devices market in 2024.”

The breast biopsy devices market is divided into five regions: North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. In 2024, North America was the market leader. This dominance can be attributed to several factors. The region boasts an exceptional healthcare infrastructure and has higher healthcare spending, which facilitates access to advanced diagnostic techniques, including minimally invasive biopsy procedures.

Additionally, the rates of breast cancer, particularly in the US, are significant. As a result, many individuals seek to detect tumors early, making accurate result interpretation crucial. Furthermore, ongoing government initiatives, such as the Breast and Cervical Cancer Mortality Prevention Act, aim to increase economic opportunities for low-income families. This means enhancing access to screening and diagnostic programs.

As of 2024, notable market players include Hologic Inc. (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Argon Medical Devices (US), Merit Medical Systems (US), and Menarini-Silicon Biosystems (Italy), among others.

Don’t miss out on business opportunities in Breast Biopsy Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/